The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.
about
The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan.Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agentsGain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulenceOne small step for a yeast--microevolution within macrophages renders Candida glabrata hypervirulent due to a single point mutationCrystal Structures of Candida albicans Dihydrofolate Reductase Bound to Propargyl-Linked Antifolates Reveal the Flexibility of Active Site Loop Residues Critical for Ligand Potency and SelectivitySystematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genesFumarate Production by Torulopsis glabrata: Engineering Heterologous Fumarase Expression and Improving Acid ToleranceAntifungal Therapy: New Advances in the Understanding and Treatment of MycosisVariation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic locationCharacterization of a new clinical yeast species, Candida tunisiensis sp. nov., isolated from a strain collection from Tunisian hospitals.Tn7-based genome-wide random insertional mutagenesis of Candida glabrata.Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative.Functional genomic analysis of fluconazole susceptibility in the pathogenic yeast Candida glabrata: roles of calcium signaling and mitochondria.Efflux in fungi: la pièce de résistanceTAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2.Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole.Fungal PDR transporters: Phylogeny, topology, motifs and function.Novel acid phosphatase in Candida glabrata suggests selective pressure and niche specialization in the phosphate signal transduction pathway.Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole.Contribution of CgPDR1-regulated genes in enhanced virulence of azole-resistant Candida glabrataInfluence of multidrug efflux systems on methylene blue-mediated photodynamic inactivation of Candida albicans.Multifunctional centromere binding factor 1 is essential for chromosome segregation in the human pathogenic yeast Candida glabrataRole of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata.In vitro and in vivo effects of 14alpha-demethylase (ERG11) depletion in Candida glabrataMicroarray and molecular analyses of the azole resistance mechanism in Candida glabrata oropharyngeal isolates.UPC2A is required for high-level azole antifungal resistance in Candida glabrata.Evolutionary divergence in the fungal response to fluconazole revealed by soft clustering.Pivotal role for a tail subunit of the RNA polymerase II mediator complex CgMed2 in azole tolerance and adherence in Candida glabrataRoles of cellular respiration, CgCDR1, and CgCDR2 in Candida glabrata resistance to histatin 5.Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants.Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testingHistatin 5 resistance of Candida glabrata can be reversed by insertion of Candida albicans polyamine transporter-encoding genes DUR3 and DUR31.Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiationLoss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in miceMultiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole.Azole resistance of Candida glabrata in a case of recurrent fungemiaMolecular mechanisms of itraconazole resistance in Candida dubliniensis.Histatin 5 uptake by Candida albicans utilizes polyamine transporters Dur3 and Dur31 proteins.Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents
P2860
Q24814052-DC079748-7B94-426A-89C1-FDCB8A315A7CQ26863344-3D154FC0-EFB4-4D28-9C9B-D0A1FC949155Q27318203-C2966F8E-C74F-4897-9F81-BD4A0A2BEDB8Q27322886-E51920E4-267E-4CF9-AEF1-047C141F5F70Q27670663-E516B88C-39E7-4FC4-B502-2C32D4731D22Q28539874-E34E9433-ED67-4F2F-8BE2-56A36C715F7BQ28554542-5BAD531C-C73D-48DD-8463-4A2606DE16D0Q28818603-EF17E6FA-EB8D-4D35-BD29-FAB88504DE37Q30452976-2E5D27C3-58F7-443F-A21E-BD0A4AE0F01CQ30573841-C38FED9F-6BFC-41CA-A6C8-A2D9ED97D49BQ30917066-C9EDA39B-A005-4F89-A8CE-A9F5906E449DQ33200348-8B1A9CD2-D502-4779-8E55-E6D2E1C2FC2BQ33202199-BA69560C-EBCE-4E12-9405-482481779E18Q33474798-CD441E47-B185-4855-98CF-CEB1D4B6411CQ33559776-D91B311E-09F9-4E13-911E-6442272A8B70Q33622915-069EEBFE-8805-4AFE-88F0-A10DDA5473CDQ33624643-80987888-CA12-4B4D-9E53-7628A4924551Q33672748-4FFFBBAD-1D3F-48C6-9195-2A9BD8580665Q33805788-F7C39549-AAB9-4A8E-AC03-9F4F4B62588FQ33806807-7F9229DE-CF13-4667-9DD4-A1ABE1F6FD34Q33847058-E968431C-3384-40BA-A0F9-C9CEF22E0D98Q33883085-83403E9E-1970-49BC-B8FE-70A5E275EE5AQ33968972-756AB897-3963-4F16-A5AB-50AEE4C037B0Q33981896-6B430BC8-AAD4-47AC-84E7-CE828D1A4494Q33983303-7CCF3AF7-B6E1-4180-A298-65F3DF1DA742Q34045265-385A9F5E-561D-4A7C-B135-D06E335CD211Q34058180-DDB9F53A-1009-464C-932F-540D3B7FFB05Q34080293-58F31C51-5993-4937-BED7-B750EE92FCFFQ34298870-AE8DFC0C-2F57-48D7-8FCF-D2F1B392D81AQ34509765-A2158C67-D2B2-4459-A73A-ACD967C10586Q34510712-05C7C35E-C033-4DC8-BBB0-8DFED0C15CF0Q34647337-36DD35E1-9868-4ECE-8D9E-8D052396BBFAQ34684434-FD98C7F8-E5D8-4826-A9BE-919E3350FD7CQ34753171-04CC0095-F0D5-460A-9F2C-C5EE1F817DA9Q34932823-9F12F78D-499A-49FC-84B7-546A6C3A9952Q34940421-6B66B212-5864-420B-9E68-1BF4E370A319Q35073016-CEB2C9C8-56E9-4DBB-B5D4-5CF95BDE5960Q35165969-A9B493D9-07FC-4D99-84B5-049A934697F2Q35626181-2DEC3023-70BE-444C-83B1-573784B5700CQ35690629-8F148938-68F7-4850-8747-99C0403E8839
P2860
The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The ATP binding cassette trans ...... es to azole antifungal agents.
@ast
The ATP binding cassette trans ...... es to azole antifungal agents.
@en
type
label
The ATP binding cassette trans ...... es to azole antifungal agents.
@ast
The ATP binding cassette trans ...... es to azole antifungal agents.
@en
prefLabel
The ATP binding cassette trans ...... es to azole antifungal agents.
@ast
The ATP binding cassette trans ...... es to azole antifungal agents.
@en
P2093
P2860
P356
P1476
The ATP binding cassette trans ...... tes to azole antifungal agents
@en
P2093
D Calabrese
P A Majcherczyk
P2860
P304
P356
10.1128/AAC.43.11.2753
P407
P577
1999-11-01T00:00:00Z